Vicente Linares

Dr. Vicente Linares

University of Seville, Seville, Spain
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAngela Aguilar-de-Leyva
Angela Aguilar-de-Leyva
VLVicente Linares
Vicente Linares
MDMarta Casas Delgado
Marta Casas Delgado
Isidoro CaraballoIsidoro Caraballo
Isidoro Caraballo
In the last few years, the employment of 3D printing technologies in the manufacture of drug delivery systems has increased, due to the advantages that they offer for personalized medicine. Thus, the possibility of producing sophisticated and tailor-made structures loaded with drugs intended for tissue engineering and optimizing the drug dose is particularly interesting in the case of pediatric and geriatric population. Natural products provide a wide range of advantages for their application as pharmaceutical excipients, as well as in scaffolds purposed for tissue engineering prepared by 3D printing technologies. The ability of biopolymers to form hydrogels is exploited in pressure assisted microsyringe and inkjet techniques, resulting in suitable porous matrices for the printing of living cells, as well as thermolabile drugs. In this review, we analyze the 3D printing technologies employed for the preparation of drug delivery systems based on natural products. Moreover, the 3D printed drug delivery systems containing natural products are described, highlighting the advantages offered by these types of excipients.

1 January 2019 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
VLVicente Linares
Vicente Linares
MDMarta Casas Delgado
Marta Casas Delgado
Isidoro CaraballoIsidoro Caraballo
Isidoro Caraballo

1 October 2021 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
AAAndreia Almeida
Andreia Almeida
VLVicente Linares
Vicente Linares
GMGloria Mora-Castaño
Gloria Mora-Castaño
MCMarta Casas
Marta Casas
ICIsidoro Caraballo
Isidoro Caraballo
Bruno SarmentoBruno Sarmento
Bruno Sarmento

22 March 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAngela Aguilar-de-Leyva
Angela Aguilar-de-Leyva
MDMarta Casas Delgado
Marta Casas Delgado
CFCarmen Ferrero
Carmen Ferrero
VLVicente Linares
Vicente Linares
Isidoro CaraballoIsidoro Caraballo
Isidoro Caraballo
The production of tailored, on-demand drug delivery systems has gained attention in pharmaceutical development over the last few years, thanks to the application of 3D printing technology in the pharmaceutical field. Recently, direct powder extrusion (DPE) has emerged among the extrusion-based additive manufacturing techniques. It is a one-step procedure that allows the direct processing of powdered formulations. The aim of this systematic literature review is to analyze the production of drug delivery systems using DPE. A total of 27 articles have been identified through scientific databases (Scopus, PubMed, and ScienceDirect). The main characteristics of the three types of 3D printers based on DPE have been discussed. The selection of polymers and auxiliary excipients, as well as the flowability of the powder mixture, the rheological properties of the molten material, and the printing temperatures have been identified as the main critical parameters for successful printing. A wide range of drug delivery systems with varied geometries and different drug release profiles intended for oral, buccal, parenteral, and transdermal routes have been produced. The ability of this technique to manufacture personalized, on-demand drug delivery systems has been proven. For all these reasons, its implementation in hospital settings in the near future seems promising.

15 April 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GMGloria Mora
Gloria Mora
MMMonica Millan-Jimenez
Monica Millan-Jimenez
VLVicente Linares
Vicente Linares
Isidoro CaraballoIsidoro Caraballo
Isidoro Caraballo
Three-dimensional (3D) printing technology enables the design of new drug delivery systems for personalised medicine. Polymers that can be molten are needed to obtain extruded filaments for Fused Deposition Modelling (FDM), one of the most frequently employed techniques for 3D printing. The aim of this work was to evaluate the extrusion process and the physical appearance of filaments made of a hydrophilic polymer and a non-molten model drug. Metformin was used as model drug and Affinisol™ 15LV as the main carrier. Drug-loaded filaments were obtained by using a single-screw extruder and, subsequently, their printability was tested. Blends containing up to a 60% and 50% drug load with 5% and 7.5% of auxiliary excipients, respectively, were successfully extruded. Between the obtained filaments, those containing up to 50% of the drug were suitable for use in FDM 3D printing. The studied parameters, including residence time, flow speed, brittleness, and fractal dimension, reflect a critical point in the extrusion process at between 30–40% drug load. This finding could be essential for understanding the behaviour of filaments containing a non-molten component.

26 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VLVicente Linares
Vicente Linares
AAAngela Aguilar-de-Leyva
Angela Aguilar-de-Leyva
MDMarta Casas Delgado
Marta Casas Delgado
Isidoro CaraballoIsidoro Caraballo
Isidoro Caraballo
Colonic drug delivery of drugs is an area of great interest due to the need to treat high prevalence colonic local diseases as well as systemic conditions that may benefit from the advantages associated to this route of drug administration. In the last decade, the use of 3D printing technologies has expanded, offering the possibility of preparing personalized medicines in small batches directly at the point of care. The aim of this work is to design a high drug loaded 3D printed system prepared by a combination of Fused Deposition Modelling (FDM) and Injection Volume Filling (IVF) techniques intended for zero-order colonic drug release. For this purpose, different batches of binary and ternary filaments based on the thermoplastic polyurethane Tecoflex EG-72D (TPU), theophylline anhydrous (AT) as model drug, and magnesium stearate as lubricant have been developed and characterized. Filaments with the highest drug load and the best rheological properties were selected for the manufacture of a printed fractal-like structure based on multiple toroids. This design was proposed to provide high surface area, leading to increased drug release and water uptake in the colonic region. This structure was 3D printed by FDM and then coated in a unique step by IVF technology using the enteric polymer DrugCoat S 12.5. This way, an additional coating process is avoided, reducing costs and production time. Studies of drug release confirmed the ability of the structures to provide a five-hour period of constant drug delivery in the colonic region.